Renin is an enzyme that plays a crucial role in the renin-angiotensin-aldosterone system (RAAS), which regulates blood pressure and fluid balance in the body. It is produced by the juxtaglomerular cells of the kidney and is responsible for the conversion of angiotensinogen to angiotensin I, a precursor to the potent vasoconstrictor angiotensin II. The study and manipulation of renin have significant implications for the treatment of hypertension and related cardiovascular diseases.
Recombinant human renin is produced using genetic engineering techniques, where the gene encoding human renin is inserted into a host cell line, such as Human Embryonic Kidney (HEK) 293 cells. This allows for the production of large quantities of renin for research and therapeutic purposes.
The preparation of recombinant human renin involves several steps:
Biochemical characterization of the recombinant enzyme shows that both binding and catalytic properties are essentially identical to previously reported activities for purified renin . This high level of purity and activity makes recombinant human renin suitable for supporting structural biology efforts, such as X-ray crystallography studies .
Recombinant human renin is used in various applications, including: